AngioDynamics to Participate in Upcoming Investor Conferences
AngioDynamics, Inc. (NASDAQ: ANGO), a leading medical technology company focused on vascular health and cancer treatment, has announced its participation in two upcoming investor conferences. The company will attend the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2024, and present at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, at 10:00 am.
Investors can access a live webcast of the Canaccord Genuity presentation through the 'Investors' section of AngioDynamics' website. These conferences provide an opportunity for the company to showcase its innovative medical technologies and engage with potential investors.
AngioDynamics, Inc. (NASDAQ: ANGO), un'azienda leader nella tecnologia medica con focus sulla salute vascolare e il trattamento del cancro, ha annunciato la sua partecipazione a due conferenze per investitori. L'azienda parteciperà alla 9ª Conferenza Annuale Virtuale MedTech & Diagnostics 1x1 di Needham il 12 agosto 2024 e presenterà alla 44ª Conferenza Annuale di Crescita di Canaccord Genuity il 13 agosto 2024, alle 10:00.
Gli investitori possono accedere a una diretta web della presentazione di Canaccord Genuity attraverso la sezione 'Investitori' del sito web di AngioDynamics. Queste conferenze offrono un'opportunità per l'azienda di mettere in mostra le sue tecnologie mediche innovative e di interagire con potenziali investitori.
AngioDynamics, Inc. (NASDAQ: ANGO), una empresa líder en tecnología médica centrada en la salud vascular y el tratamiento del cáncer, ha anunciado su participación en dos próximas conferencias para inversores. La empresa asistirá a la 9ª Conferencia Anual Virtual MedTech & Diagnostics 1x1 de Needham el 12 de agosto de 2024 y presentará en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity el 13 de agosto de 2024, a las 10:00 a.m.
Los inversores pueden acceder a una transmisión web en vivo de la presentación de Canaccord Genuity a través de la sección 'Inversores' en el sitio web de AngioDynamics. Estas conferencias ofrecen una oportunidad para que la empresa muestre sus tecnologías médicas innovadoras e interactúe con posibles inversores.
AngioDynamics, Inc. (NASDAQ: ANGO), 혈관 건강 및 암 치료에 중점을 둔 선도적인 의료 기술 회사가 두 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 2024년 8월 12일 제9회 니다움 가상 MedTech 및 진단 1x1 회의에 참석하고, 2024년 8월 13일 오전 10:00에 캐나코드 제네위티 제44회 연례 성장 회의에서 발표할 예정입니다.
투자자들은 AngioDynamics 웹사이트의 '투자자' 섹션을 통해 Canaccord Genuity 발표의 생방송 웹캐스트에 접근할 수 있습니다. 이 회의는 회사가 혁신적인 의료 기술을 선보이고 잠재적 투자자와 소통할 수 있는 기회를 제공합니다.
AngioDynamics, Inc. (NASDAQ: ANGO), une entreprise leader en technologie médicale axée sur la santé vasculaire et le traitement du cancer, a annoncé sa participation à deux prochaines conférences pour investisseurs. L'entreprise assistera à la 9ᵉ Conférence Annuelle Virtuelle MedTech & Diagnostics 1x1 de Needham le 12 août 2024 et présentera à la 44ᵉ Conférence Annuelle de Croissance de Canaccord Genuity le 13 août 2024 à 10h00.
Les investisseurs peuvent accéder à un webinaire en direct de la présentation de Canaccord Genuity via la section 'Investisseurs' du site web d'AngioDynamics. Ces conférences offrent à l'entreprise l'opportunité de mettre en avant ses technologies médicales innovantes et d'interagir avec des investisseurs potentiels.
AngioDynamics, Inc. (NASDAQ: ANGO), ein führendes Unternehmen der Medizintechnologie mit Schwerpunkt auf vaskulärer Gesundheit und Krebsbehandlung, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird an der 9. jährlichen virtuellen MedTech & Diagnostics 1x1 Konferenz von Needham am 12. August 2024 teilnehmen und am 13. August 2024 um 10:00 Uhr auf der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity präsentieren.
Investoren können über den Bereich 'Investoren' auf der Website von AngioDynamics auf einen Live-Webcast der Präsentation von Canaccord Genuity zugreifen. Diese Konferenzen bieten der Firma die Möglichkeit, ihre innovativen Medizintechnologien zu präsentieren und mit potenziellen Investoren in Kontakt zu treten.
- None.
- None.
9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Date: August 12, 2024
Canaccord Genuity 44th Annual Growth Conference
Presentation: August 13, 2024 at 10:00am
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240729308520/en/
Investors:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
When is AngioDynamics (ANGO) presenting at the Canaccord Genuity 44th Annual Growth Conference?
Which investor conferences is AngioDynamics (ANGO) participating in during August 2024?
How can investors access AngioDynamics' (ANGO) presentation at the Canaccord Genuity conference?
What is the focus of AngioDynamics (ANGO) as a medical technology company?
